The Oncology Research Department at The Queen’s Medical Center improves our approach to cancer care in Hawaii by supporting cancer research. Our cancer research team includes physician researchers, nurses and scientists dedicated to implementing and carrying out clinical trials designed specifically for cancer patients.
Queen’s Cancer Center and the University of Hawaii Cancer Center (UHCC) are selected minority based sites for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). The goal of NCORP is to bring cancer clinical trials and cancer care delivery research to people in their own communities to improve patient outcomes and reduce cancer disparities.
Because of this relationship, the Oncology Research Department at Queen’s Cancer Center is able to offer research studies that are available through the NCI National Cancer Trials Network, pharmaceutical companies and local investigators. Our team of experienced oncologists carefully selects only the trials that show promise and potential benefit to our patients. Once a trial is chosen, our staff works closely with the sponsor and regulatory boards to make the study available to our patients.
All research studies are approved through the UHCC’s Community Research Advocacy Board and the Protocol Review Monitoring Committee to ensure the trials are scientifically sound and the patient is being protected.
Clinical trials provide patients opportunities to be a part of the fight to end cancer. The trials help to improve the way oncology experts prevent, diagnose and even treat the disease.
This journey started in 2015 when The Queen’s Medical Center became a certified member of MD Anderson Cancer Network®, a program of MD Anderson Cancer Center. This designation has allowed certified Queen’s medical oncologists, radiation oncologists, and surgeons to have access to MD Anderson’s evidence-based guidelines for the purpose of screening, diagnosis, treatment, follow-up care, and elevating the quality of cancer care provided. This network has also allowed certified Queen’s multidisciplinary oncology providers to collaborate on patient care with MD Anderson’s experts, who are among the nation’s top cancer care physicians and leading experts in cancer research.
Queen’s currently conducts many NCI, pharmaceutical company and local investigator clinical research studies through our affiliation with the UHCC. Now, for the first time, we are also able to offer select MD Anderson clinical trials, which will continue to aid us in the fight against cancer.
All clinical trials have specific requirements for eligibility. Please ask your doctor if you are a candidate. By participating in clinical trials, you can help us in our mission to end cancer.
If you are interested in a clinical trial, The Queen’s Cancer Research Department can be reached at 808-691-8548. Your doctor or study nurse can also contact us, and help determine if a clinical trial is right for you.